These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2330454)

  • 21. [Combined valvular and coronary surgery].
    Sorribas Berjón JF; Cuenca Castillo JJ; Juffé Stein A
    Rev Esp Cardiol; 1998; 51 Suppl 3():34-9. PubMed ID: 9717400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of continuous warm blood cardioplegia in cardiac valve re-replacement.
    Nagaoka H; Hirooka K; Ohnuki M; Fujiwara N
    J Heart Valve Dis; 1999 Mar; 8(2):124-30. PubMed ID: 10224569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intraoperative myocardial protection with extracellular cardioplegic solutions in patients with cardiac valve diseases].
    Zhidkov IL; Ivanov VA; Kozhevnikov VA; Charnaia MA; Mukhamedzianova AR; Trekova NA
    Anesteziol Reanimatol; 2007; (2):38-42. PubMed ID: 17563998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardioplegia by minicardioplegia technique].
    Türköz R; Gülcan O; Türköz A
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):178-9. PubMed ID: 16766286
    [No Abstract]   [Full Text] [Related]  

  • 25. [Retrograde coronary sinus perfusion: a method of myocardial protection in aortic valve surgery].
    Abe T; Nieda S; Takahashi M; Okubo Y; Yamamoto H
    Rinsho Kyobu Geka; 1981; 1(3):383-8. PubMed ID: 7052611
    [No Abstract]   [Full Text] [Related]  

  • 26. Perioperative assessment of the quality of myocardial protection.
    Fabiani JN; Jebara V; Carpentier A
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 4():797-803. PubMed ID: 2093368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An asanguineous reperfusion solution. An effective adjunct to cardioplegic protection in high-risk valve operations.
    Menasche P; Dunica S; Kural S; Touchot B; Chollet A; Steg G; Levard G; Lorente P; Piwnica A
    J Thorac Cardiovasc Surg; 1984 Aug; 88(2):278-86. PubMed ID: 6748722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary sinus retroperfusion for myocardial protection: pragmatic observations and caveats based on a large experience.
    Menasche P
    Adv Card Surg; 1993; 4():157-72. PubMed ID: 8252253
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of Na movement on surgical myocardial protection: the role of the Na+-H+ exchange system and Na-channel in the development of ischemia and reperfusion injury.
    Liu KX; Yamamoto F; Yamamoto H; Wang T; Zhu Z; Xu R; Zhang S
    Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):301-7. PubMed ID: 17954986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioplegic rearrest: clinical experience with 12 patients.
    Salerno TA; Chiong MA; Neilson IR; Charrette EJ
    Can J Surg; 1981 Nov; 24(6):649-50, 655. PubMed ID: 6976823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myocardial protection].
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Apr; 30(4):610-25. PubMed ID: 7119521
    [No Abstract]   [Full Text] [Related]  

  • 33. The short-term and long-term effects of warm or tepid cardioplegia.
    Mallidi HR; Sever J; Tamariz M; Singh S; Hanayama N; Christakis GT; Bhatnagar G; Cutrara CA; Goldman BS; Fremes SE
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):711-20. PubMed ID: 12658215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of myocardial metabolism with microdialysis after protection with cold blood- or cold crystalloid cardioplegia. A porcine model.
    Runge M; Hughes P; Peter Gøtze J; Petersen RH; Steinbrüchel DA
    Scand Cardiovasc J; 2006 Jun; 40(3):186-93. PubMed ID: 16798667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin cardioplegia for elective coronary bypass surgery.
    Doenst T; Ayres BE; Beyersdorf F
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1221-2. PubMed ID: 11385404
    [No Abstract]   [Full Text] [Related]  

  • 36. [Myocardial protection in surgery of the arrested open heart (author's transl)].
    Moll J; Sadowski R
    Zentralbl Chir; 1982; 107(8):434-9. PubMed ID: 7102150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperpolarized cardiac arrest with ATP-sensitive potassium channel opener on myocardial protection during CPB].
    Yu T; Liu X; Yu Z; Yang S; Ye Y; Yang X; Gao Z
    Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):931-4. PubMed ID: 11832201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antegrade-retrograde-warm cardioplegia of myocardial protection in the serious heart valve disease].
    Mu R; Zhou LY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jul; 16(7):434-5. PubMed ID: 15238190
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental study on myocardial protection by adjunct use of carperitide (hANP) in cardiac surgery.
    Wakui S
    Ann Thorac Cardiovasc Surg; 2005 Feb; 11(1):12-20. PubMed ID: 15788963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental studies of myocardial protection factors and clinical studies of protection with GIK].
    Kitamura N; Natsuaki M; Nagara H; Nakae S; Shimazu K
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):467-9. PubMed ID: 469309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.